19/04/2014 03:43:25 Free Membership Login

Celera News (NASDAQ:CRA)

DateTimeSource
Headline
05/17/20115:45PMPRNUSQuest Diagnostics Successfully Completes Acquisition of Celera
Quest Diagnostics Successfully Completes Acquisition of Celera PR Newswire MADISON, N.J., May 17, 2011 MADISON, N.J., May 17, 2011 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today the successful completion of its acquisition... More...>>
05/11/20119:27AMDJNQuest Diagnostics To Complete Celera Deal Through Short-Form Merger
DOW JONES NEWSWIRES Quest Diagnostics Inc. (DGX) plans to complete its deal for genetics-diagnostics test developer Celera Corp. (CRA) through a short-form merger, as the company announced that it held 61% of Celera's shares after the closing of tender offer, which had been extended several times. As of Tuesday's deadline... More...>>
05/11/20118:00AMPRNUSQuest Diagnostics Announces Completion of Final Extension of the Subsequent Offering Period and Intent to Exercise Top-Up Option
Quest Diagnostics Announces Completion of Final Extension of the Subsequent Offering Period and Intent to Exercise Top-Up Option and Complete Merger PR Newswire MADISON, N.J., May 11, 2011 MADISON, N.J., May 11, 2011 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic... More...>>
05/09/20118:00AMPRNUSQuest Diagnostics Announces Final Extension of Subsequent Offering Period for Shares of Celera
Quest Diagnostics Announces Final Extension of Subsequent Offering Period for Shares of Celera Offer Concludes at 5 p.m. Tomorrow, Tuesday, May 10th PR Newswire MADISON, N.J., May 9, 2011 MADISON, N.J., May 9, 2011 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing... More...>>
05/04/20118:00AMPRNUSQuest Diagnostics Announces Successful Tender Offer and Commencement of a Subsequent Offering Period for Shares of Celera
Quest Diagnostics Announces Successful Tender Offer and Commencement of a Subsequent Offering Period for Shares of Celera PR Newswire MADISON, N.J., May 4, 2011 MADISON, N.J., May 4, 2011 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services... More...>>
05/03/20118:00AMPRNUSQuest Diagnostics Announces One Day Extension of Offer to Acquire Celera to 5pm Today
Quest Diagnostics Announces One Day Extension of Offer to Acquire Celera to 5pm Today Over 52% of Fully-Diluted Shares Tendered to Date, Including Guaranteed Shares PR Newswire MADISON, N.J., May 3, 2011 MADISON, N.J., May 3, 2011 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider... More...>>
04/29/20112:20PMZACKSEarnings Scorecard: Quest Diagnostics - Analyst Blog
The announcement of Quest Diagnostics’ (DGX) first quarter of fiscal 2011 results as on April 20, 2011, has triggered analysts to revise estimates downwards. Previous quarter highlights Quest Diagnostics reported an adjusted EPS of $1.00 during the first quarter of fiscal 2011, a penny above the Zacks Consensus Estimate... More...>>
04/21/201110:08AMZACKSLabCorp Beats, Raises EPS Guidance - Analyst Blog
Leading lab-testing company Laboratory Corporation of America Holdings (LH) reported adjusted EPS of $1.52 (excluding amortization, restructuring and other special charges) for the first quarter of fiscal 2011. That was way above the Zacks Consensus Estimate of $1.44 and the previous year's adjusted EPS of $1.40. Moreover... More...>>
04/21/201110:08AMZACKSLabCorp Beats, Raises EPS Guidance - Analyst Blog
Leading lab-testing company Laboratory Corporation of America Holdings (LH) reported adjusted EPS of $1.52 (excluding amortization, restructuring and other special charges) for the first quarter of fiscal 2011. That was way above the Zacks Consensus Estimate of $1.44 and the previous year's adjusted EPS of $1.40. Moreover... More...>>
04/20/20114:15PMBWCelera Provides Update on Recent Scientific Findings on KIF6 and PMA Application
Celera Corporation (NASDAQ:CRA) today provided an update on recent scientific findings pertaining to the KIF6 gene variant and its pre-market approval application (PMA) with the United States Food and Drug Administration (FDA) for its KIF6 Genotyping Assay. In nine previously published peer-reviewed articles on genetic... More...>>
04/20/201111:09AMZACKSEarnings Preview: Quest Diagnostics - Analyst Blog
Quest Diagnostics (DGX) is scheduled to release its first quarter fiscal 2011 results on Wednesday, April 20, 2011 before the market opens. The company is expected to earn 99 cents during the quarter on $1,806 million in revenues, according to the Zacks Consensus Estimate. Previous Quarter Highlights Quest reported an... More...>>
04/20/20118:54AMZACKSQuest Diagnostics Beats by a Penny - Analyst Blog
Quest Diagnostics (DGX) reported an adjusted EPS of $1.00 during the first quarter of fiscal 2011, a penny above the Zacks Consensus Estimate and the year-ago quarter. Revenues for the quarter increased 1% year over year to $1.8 billion, in line with the Zacks Consensus Estimate. A 10.5% decline in the number of outstanding... More...>>


NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nasdaq cra140419 03:43